Fidelity Investments
TMO icon

Fidelity Investments’s Thermo Fisher Scientific TMO Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$1.62B Sell
3,991,001
-651,544
-14% -$264M 0.09% 176
2025
Q1
$2.31B Sell
4,642,545
-1,694,832
-27% -$843M 0.15% 111
2024
Q4
$3.3B Sell
6,337,377
-1,540,082
-20% -$801M 0.2% 69
2024
Q3
$4.87B Buy
7,877,459
+1,294,453
+20% +$801M 0.3% 46
2024
Q2
$3.64B Sell
6,583,006
-334,967
-5% -$185M 0.23% 64
2024
Q1
$4.02B Sell
6,917,973
-931,572
-12% -$541M 0.27% 53
2023
Q4
$4.17B Sell
7,849,545
-470,479
-6% -$250M 0.32% 45
2023
Q3
$4.21B Sell
8,320,024
-890,117
-10% -$451M 0.36% 41
2023
Q2
$4.81B Sell
9,210,141
-2,143,903
-19% -$1.12B 0.4% 37
2023
Q1
$6.54B Buy
11,354,044
+194,602
+2% +$112M 0.6% 21
2022
Q4
$6.15B Buy
11,159,442
+187,914
+2% +$103M 0.61% 20
2022
Q3
$5.56B Buy
10,971,528
+987,695
+10% +$501M 0.58% 20
2022
Q2
$5.42B Sell
9,983,833
-316,878
-3% -$172M 0.54% 23
2022
Q1
$6.08B Sell
10,300,711
-800,254
-7% -$473M 0.49% 24
2021
Q4
$7.41B Sell
11,100,965
-313,678
-3% -$209M 0.55% 22
2021
Q3
$6.52B Buy
11,414,643
+1,279,984
+13% +$731M 0.52% 26
2021
Q2
$5.11B Sell
10,134,659
-1,840,322
-15% -$928M 0.4% 34
2021
Q1
$5.47B Sell
11,974,981
-1,048,006
-8% -$478M 0.47% 29
2020
Q4
$6.07B Buy
13,022,987
+686,768
+6% +$320M 0.54% 21
2020
Q3
$5.45B Buy
12,336,219
+715,208
+6% +$316M 0.55% 25
2020
Q2
$4.21B Buy
11,621,011
+376,531
+3% +$136M 0.46% 29
2020
Q1
$3.19B Sell
11,244,480
-1,251,745
-10% -$355M 0.44% 38
2019
Q4
$4.06B Sell
12,496,225
-191,300
-2% -$62.1M 0.45% 34
2019
Q3
$3.7B Buy
12,687,525
+240,837
+2% +$70.1M 0.44% 33
2019
Q2
$3.66B Buy
12,446,688
+874,107
+8% +$257M 0.43% 35
2019
Q1
$3.17B Buy
11,572,581
+2,900,868
+33% +$794M 0.38% 42
2018
Q4
$1.94B Buy
8,671,713
+2,172,574
+33% +$486M 0.27% 68
2018
Q3
$1.59B Buy
6,499,139
+1,016,082
+19% +$248M 0.18% 101
2018
Q2
$1.14B Sell
5,483,057
-637,773
-10% -$132M 0.13% 151
2018
Q1
$1.26B Buy
6,120,830
+837,692
+16% +$173M 0.15% 138
2017
Q4
$1B Sell
5,283,138
-874,564
-14% -$166M 0.12% 183
2017
Q3
$1.17B Buy
6,157,702
+2,567,657
+72% +$486M 0.14% 145
2017
Q2
$626M Sell
3,590,045
-65,002
-2% -$11.3M 0.08% 265
2017
Q1
$561M Sell
3,655,047
-1,232,458
-25% -$189M 0.07% 287
2016
Q4
$690M Sell
4,887,505
-3,006,181
-38% -$424M 0.09% 231
2016
Q3
$1.26B Sell
7,893,686
-322,959
-4% -$51.4M 0.17% 121
2016
Q2
$1.21B Buy
8,216,645
+834,858
+11% +$123M 0.17% 130
2016
Q1
$1.05B Sell
7,381,787
-821,794
-10% -$116M 0.14% 146
2015
Q4
$1.16B Sell
8,203,581
-1,132,421
-12% -$161M 0.16% 132
2015
Q3
$1.14B Sell
9,336,002
-2,158,889
-19% -$264M 0.16% 129
2015
Q2
$1.49B Sell
11,494,891
-1,186,866
-9% -$154M 0.19% 107
2015
Q1
$1.7B Buy
12,681,757
+33,359
+0.3% +$4.48M 0.22% 88
2014
Q4
$1.58B Buy
12,648,398
+1,645,184
+15% +$206M 0.21% 101
2014
Q3
$1.34B Sell
11,003,214
-852,498
-7% -$104M 0.18% 118
2014
Q2
$1.4B Sell
11,855,712
-1,922,385
-14% -$227M 0.19% 114
2014
Q1
$1.66B Buy
13,778,097
+126,762
+0.9% +$15.2M 0.23% 87
2013
Q4
$1.52B Buy
13,651,335
+1,492,208
+12% +$166M 0.21% 99
2013
Q3
$1.12B Buy
12,159,127
+3,238,896
+36% +$298M 0.17% 126
2013
Q2
$755M Buy
+8,920,231
New +$755M 0.12% 178